Pelagospharma
1 known investors
Pelagos Pharma is a therapeutics developer working on "exercise mimetics," drug candidates designed to activate the metabolic, mitochondrial, and structure-function pathways associated with the benefits of aerobic exercise. The company targets diseases linked to aging and increasingly sedentary lifestyles.
BiotechHealthtechLongevity
Investors · 1
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2022 | $540.4K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.